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Abstract
Amyloidosis is a heterogeneous group of diseases characterized by the extracellular deposition of insoluble proteins whose
pathogenesis is not yet fully understood. The deposition of amyloid proteins can be systemic or localized, idiopathic or related to
systemic diseases, mostly multiple myeloma or chronic inflammatory diseases. Localized head and neck amyloidosis is a rare
entity, mainly involving the larynx. Given the rarity of the disease and the absence of a lasting follow-up protocol, there is no
standard treatment defined for localized amyloidosis. We report a rare case of localized nasopharyngeal amyloidosis, treated with
complete transoral resection and confirmed by histological examination.
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Introduction
Amyloidosis is a heterogeneous group of diseases character-
ized by the deposition of insoluble proteins in the extracellular
space. The deposition of amyloid proteins can be systemic or
localized.1,2
The systemic form can be idiopathic or related to systemic
disease, mainly multiple myeloma or chronic inflammatory
diseases. Localized nasopharyngeal amyloidosis is an
extremely rare entity with few cases reported in the literature.
Amyloidosis can be suspected based on clinical signs and
imaging studies but the definitive diagnosis requires tissue
biopsy, analyzed using Congo red staining combined with polar-
ized light and possibly immunohistochemical characterization of
the proteins. There is no specific cure for amyloidosis and treat-
ment depends on the form of the disease, the organs affected, and
the underlying condition. We describe a case of an 80-year-old
woman with a primary localized nasopharyngeal amyloidosis.
Case Report
An 80-year-old woman presented with a 5-month history of pro-
gressive nasal obstruction. The patient had undergone right
superior lobectomy for primitive lung adenocarcinoma and
hystero-salpingo-oophorectomy for endometrial carcinoma. On
admission to our department, there was no evidence of recurrent
disease.
Endoscopy revealed a yellowish smooth bulging mass
involving the posterior wall of the nasopharynx (Figure 1).
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Figure 1. Endoscopy revealed a yellowish smooth bulging mass
involving the posterior wall of the nasopharynx.
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Maxillofacial magnetic resonance imaging showed a submuco-
sal mass (26 14 43 mm) involving the posterior wall of the
nasopharynx, characterized by polycyclic margins, homoge-
neous contrast enhancement, isointensity with muscles in T1
and T2 acquisitions, and hyperintensity in Short-TI Inversion
Recovery images, without infiltrative aspects (Figure 2).
A total body computed tomography (CT) scan showed no other
solid lesions. The nasopharyngeal mass had inhomogeneous
contrast enhancement and was accompanied by 2 retropharyn-
geal nodes.
Considering the radiologic features, the poor vasculariza-
tion and the distance from the large neck vessels, a complete
transoral resection was carried out. The surgical specimen
was routinely processed. The postoperative period was
uneventful.
Microscopic examination revealed a submucosal deposi-
tion of cloudy, ill-defined pinkish material highly suspicious
for amyloid deposition (Figure 3). Specific Congo red stain-
ing was performed and revealed apple-green birefringence
under polarized light (Figure 4). Multiple attempts were made
to further characterize the type of amyloid proteins using
immunohistochemistry but with negative results, thus a diag-
nosis of nasopharyngeal amyloid deposition, unspecific type,
was made.
Consequently, a complete work-up was performed, ruling
out systemic involvement and conditions possibly related to a
secondary form of amyloidosis. A diagnosis of localized naso-
pharyngeal amyloidosis was then postulated. Twenty-four
months after surgery, our patient is in good condition and
disease-free, undergoing regular clinical endoscopic and radi-
ological follow-up.
Discussion
Amyloidosis is a rare clinical entity, characterized by the extra-
cellular deposition of proteinaceous material comprised of var-
ious abnormal proteins known as amyloid fibrils.3 Amyloid
deposits result from a soluble precursor protein which is mis-
folded resulting in the deposition of insoluble amyloid fibrils.4
Amyloidosis is defined as localized if the amyloid deposition is
limited to the tissue where its precursor protein is produced,
and as systemic if the precursor protein is produced in a certain
part of the body and thereafter transported to the site where the
amyloid is found.5
The modern classification of amyloidosis uses an abbrevia-
tion of the predominant protein, preceded by the letter A.
Among the systemic forms, there are immunoglobulin light
chain amyloidosis (AL), acute phase protein amyloidosis
(AA), dialysis-related amyloidosis (Ab2M, b2 microglobulin),
and age-related amyloidosis (ATTR, transthyretin).
Microscopically, amyloidosis is characterized by deposition
of ill-defined pink material. In the localized form, a plasma cell
infiltrate is described.6 Congo red staining confirms the amy-
loid nature with a classic apple-green birefringence. Immuno-
histochemistry with commercially available antibodies should
be performed in order to characterize the protein component.
Clinical presentation depends on the organs affected by the
deposit. The kidneys are frequently involved in AL amyloido-
sis and this can lead to kidney failure; the same loss of function
can affect the heart or lungs. In the head and neck region, the
Figure 2. Maxillofacial magnetic resonance imaging showed a submucosal mass (26  14  43 mm) involving the posterior wall of the
nasopharynx, characterized by polycyclic margins, homogeneous contrast enhancement, isointensity with muscles in T1 and T2 acquisitions, and
hyperintensity in Short-TI Inversion Recovery (STIR) images, without infiltrative aspects.
Figure 3. Microscopic examination revealed a submucosal deposition
of cloudy, ill-defined pinkish material highly suspicious for amyloid
deposition.
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most frequent symptoms are hoarseness and dyspnea in laryn-
geal forms, or macroglossia in cases with oral cavity
involvement.6
The prognosis of the AA form depends on the condition
responsible for the amyloidosis itself. The AL amyloidosis can
be treated with chemotherapy and stem cell transplantation; on
the other hand, the AA form is treated aiming to cure the
underlying disease. Localized amyloidosis in the head and neck
region is rare. Most cases reported have been described in the
larynx (60%), oropharynx (23%), trachea (9%), orbit (4%), and
nasopharynx (3%).7-9
Nasopharyngeal amyloidosis is extremely rare. In their
review in 2007, Panda et al described only 13 cases in over 70
years of activity (1935-2007).10 Lately, there has been an
increase in the number of reported cases, perhaps due to
improvements in endoscopic and radiologic diagnostic tools.11,12
Patients with nasopharyngeal amyloidosis mainly complain
of nasal obstruction, epistaxis, posterior rhinorrhea, and hear-
ing impairment.13 Endoscopy generally shows an irregular,
heterogeneously yellowish, smooth bulging mass.14 On CT
scan, these lesions usually appear as a well-defined, homoge-
nous, smooth soft tissue mass without evidence of bony ero-
sion.15 It has also been reported to mimic slow-growing tumors
and sometimes to appear as densely calcified lesions.16
Imaging can help to define the extent of the disease but there
are no characteristic imaging findings, so the diagnosis cannot
be made without a biopsy or excision.17,18 Diagnosis is then
confirmed by histopathology, with characteristic apple-green
birefringence on microscopy using Congo red staining com-
bined with polarized light.
Given the rarity of the disease and the absence of a lasting
follow-up protocol, no standard treatment has been defined for
localized amyloidosis. Treatment of local disease is by com-
plete excision when this is possible without significant anato-
mical or functional sequelae, followed by routine surveillance
for recurrence. Clinical follow-up is by endoscopic examina-
tion, supported by imaging when a recurrence is suspected,
based on signs and symptoms.
At present, there is no evidence in the literature suggesting a
progression from nontreated localized head and neck
amyloidosis to systemic disease.19 Thus, at present, there is
an ongoing debate between surgical excision, preferred when
the disease causes morbidity, and a wait-and-see approach.
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